Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by Betteryear2on Mar 29, 2022 8:16am

297 Views

Post# 34554612

Advancements to its Sample Preparation Cartridge TSX-V: LXG

BEVERLY, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System, a fully automated rapid pathogen testing device, today announced advancements to its sample preparation cartridge for processing complex samples.

LexaGene Announces Advancements to its Sample Preparation Cartridge for the Veterinary Market

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments